Prevention of nevirapine-associated rash

Lancet. 2001 Feb 3;357(9253):392. doi: 10.1016/S0140-6736(05)71524-5.
No abstract available

Publication types

  • Clinical Trial
  • Comment
  • Letter

MeSH terms

  • Anti-HIV Agents / administration & dosage*
  • Anti-HIV Agents / adverse effects
  • Drug Eruptions / etiology
  • Drug Eruptions / prevention & control*
  • Humans
  • Nevirapine / administration & dosage*
  • Nevirapine / adverse effects

Substances

  • Anti-HIV Agents
  • Nevirapine